Bio View

Bio View Goodwill

Iegūtā prēmija no Bio View (BIOV.TA) uz 2026. g. 27. okt..

Goodwill

-ILS

Pēdējoreiz atjaunināts:

Iegūtā prēmija no Bio View ir 2026 - ILS. Iegūtā prēmija no Bio View bija 2025 - ILS. Tas samazinās par % zemāks salīdzinājumā ar iepriekšējo gadu.

Iegūstiet šos datus caur Eulerpool API

100 000 pieprasījumu/mēn. bez maksas · bez kartes

Bio View Akciju analīze

Ko dara Bio View? BioView Ltd. generates revenue through the sale and servicing of its Duet automated cell diagnostic system, designed for use in cytology, cytogenetic, hematology, and pathology laboratories. The Duet system enables automated detection, classification, analysis, and counting of cells, offering unique capabilities in analyzing both cell morphology and genetic content simultaneously. Additional products include the ALLEGRO workstation for automated scanning of FISH probes without Brightfield scanning and the ACCORD workstation for semi-automated imaging of FISH in breast cancer (Her-2/Neu) analysis and FISH on tissue. These systems target medical professionals in cancer diagnosis, minimal-residual disease monitoring, prenatal and postnatal cytogenetic analyses, sperm cell studies, and rare-cell detection. The company's primary customers are laboratories specializing in cytology, cytogenetics, hematology, and pathology, including those focused on cancer diagnostics and genetic analysis. These institutions purchase the Duet system for routine diagnostic workflows and the ALLEGRO and ACCORD workstations for specialized applications such as FISH analysis in breast cancer and genetic studies. BioView Ltd. also provides ongoing servicing and support for its systems, contributing to recurring revenue streams. BioView Ltd. markets its products under the brand names Duet, ALLEGRO, and ACCORD, with the Duet system serving as the core offering for general cell analysis. The ALLEGRO and ACCORD workstations cater to niche applications in FISH-based diagnostics, particularly in oncology and genetic testing. The company's revenue is derived from direct sales of these systems to healthcare facilities and laboratories, with no mention of third-party partnerships or additional revenue streams beyond product sales and servicing. Bio View ir viens no populārākajiem uzņēmumiem Eulerpool.

Bieži uzdotie jautājumi par Bio View akciju

Vietnē Eulerpool varat atrast pilnīgu Iegūtā prēmija Bio View vēsturisko attīstību kopš 2006. gada — ar gada vērtībām, grafikiem un detalizētu analīzi.

Nemateriālā vērtība rodas iegādes darījumos, kad samaksātā cena pārsniedz iegūto neto aktīvu patieso vērtību.

Rādītāji ietekmē akciju vērtējumu, signalizējot par peļņas kvalitāti, finansiālo veselību un izaugsmes trajektoriju. Spēcīgi rādītāji parasti noved pie augstākiem vērtējumiem.

Iegūstiet šos datus caur Eulerpool API

100 000 pieprasījumu/mēn. bez maksas · bez kartes

Bilance — Bio View

Visas kategorijas